GENinCode

Oxford, United Kingdom

GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.

$5.1M raised

Dec 2023

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has GENinCode raised?

GENinCode has raised $5.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2023.

Who are GENinCode's investors?

GENinCode's investors include Maven Capital Partners.

Where is GENinCode headquartered?

GENinCode is headquartered in Oxford, United Kingdom.

What does GENinCode do?

GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.

What stage is GENinCode at?

GENinCode is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 21, 2023.

MLA

"GENinCode — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/genincode. Accessed July 2, 2026.

APA

VCBacked. (2023). GENinCode — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/genincode

Wikipedia (cite web)

{{cite web |title=GENinCode — Funding & Investors |url=https://www.vcbacked.co/company/genincode |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 21, 2023.